tetano
Editor, Senior Moderator
JMIR Diabetes. 2020 May 11. doi: 10.2196/19581. [Epub ahead of print]
The challenges of COVID-19 for people living with diabetes: considerations for digital health.
Gamble A[SUP]1[/SUP], Pham Q[SUP]1,[/SUP][SUP]2[/SUP], Goyal S[SUP]1,[/SUP][SUP]2[/SUP], Cafazzo JA[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].
Author information
Abstract
The coronavirus disease 2019 (COVID-19) is a global pandemic that significantly impacts people living with diabetes. Diabetes-related factors of glycemic control, medication pharmacodynamics, social distancing, and insulin access can impact the severity of COVID-19 infection. In this commentary, we explore how digital health can support the diabetes community through the pandemic. For those living with diabetes, digital health presents the opportunity to access care with greater convenience while not having to expose themselves to infection in an in-person clinic. Digital diabetes applications can increase agency in self-care and produce clinically significant improvement in glycemic control through facilitating the capture of diabetes device data. However, the ability to share these data back to the clinic to inform virtual care and enhance diabetes coaching and guidance remains a challenge. In the end, it requires an unnecessarily high level of technical sophistication on the clinic's part and on those living with diabetes to routinely use their diabetes device data in clinic visits, virtual or otherwise. As the world comes together to fight the COVID-19 pandemic, close collaboration among the global diabetes community is critical to understand and manage the sustained impact of the pandemic on people living with diabetes.
PMID:32392473DOI:10.2196/19581
Free full text
The challenges of COVID-19 for people living with diabetes: considerations for digital health.
Gamble A[SUP]1[/SUP], Pham Q[SUP]1,[/SUP][SUP]2[/SUP], Goyal S[SUP]1,[/SUP][SUP]2[/SUP], Cafazzo JA[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].
Author information
Abstract
The coronavirus disease 2019 (COVID-19) is a global pandemic that significantly impacts people living with diabetes. Diabetes-related factors of glycemic control, medication pharmacodynamics, social distancing, and insulin access can impact the severity of COVID-19 infection. In this commentary, we explore how digital health can support the diabetes community through the pandemic. For those living with diabetes, digital health presents the opportunity to access care with greater convenience while not having to expose themselves to infection in an in-person clinic. Digital diabetes applications can increase agency in self-care and produce clinically significant improvement in glycemic control through facilitating the capture of diabetes device data. However, the ability to share these data back to the clinic to inform virtual care and enhance diabetes coaching and guidance remains a challenge. In the end, it requires an unnecessarily high level of technical sophistication on the clinic's part and on those living with diabetes to routinely use their diabetes device data in clinic visits, virtual or otherwise. As the world comes together to fight the COVID-19 pandemic, close collaboration among the global diabetes community is critical to understand and manage the sustained impact of the pandemic on people living with diabetes.
PMID:32392473DOI:10.2196/19581
Free full text